Company profile: YorkTest
1.1 - Company Overview
Company description
- Provider of food intolerance programs and diagnostic testing services, providing personalized information and support to help optimize health and wellbeing.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to YorkTest
Padlock Therapeutics
HQ: United States
Website
- Description: Provider of medicines in development targeting protein-arginine deiminases (PADs), enzymes involved in the generation of autoantigens, inflammation, and immune complexes in autoimmune diseases. The company aims to explore the full biological and therapeutic footprint of protein deimination by PADs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Padlock Therapeutics company profile →
Reneo Pharmaceuticals
HQ: United States
Website
- Description: Provider of therapies in development for rare genetic mitochondrial and orphan metabolic diseases. Develops mavodelpar (REN001) for primary mitochondrial myopathies (PMM) and long-chain fatty acid oxidation disorders (LC-FAOD), with a global Phase 2b trial in PMM and completed exploratory Phase 1b trials in LC-FAOD and McArdle disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reneo Pharmaceuticals company profile →
Resolvyx
HQ: United States
Website
- Description: Provider of therapeutics based on small molecule lipid mediators for the treatment of inflammatory diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resolvyx company profile →
Dianthus Therapeutics
HQ: United States
Website
- Description: Provider of targeted therapeutics for serious autoimmune diseases, including DNTH103, a long-acting monoclonal antibody that selectively inhibits active C1s in the classical complement pathway. DNTH103 is in Phase 2 for generalized myasthenia gravis, with plans for multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy, using YTE half-life extension for less frequent dosing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dianthus Therapeutics company profile →
Fumapharm
HQ: Switzerland
Website
- Description: Provider of pharmaceuticals as a privately held company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fumapharm company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for YorkTest
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to YorkTest
2.2 - Growth funds investing in similar companies to YorkTest
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for YorkTest
4.2 - Public trading comparable groups for YorkTest
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →